Literature DB >> 27189132

A Meta-Analysis of the Association of Chronic Obstructive Pulmonary Disease with Abdominal Aortic Aneurysm Presence.

Hisato Takagi1, Takuya Umemoto2.   

Abstract

BACKGROUND: Several case-control and population-based abdominal aortic aneurysm (AAA) screening studies have reported inconclusive results of the association of chronic obstructive pulmonary disease (COPD) with AAA presence. To determine whether COPD is associated with AAA presence, we performed a meta-analysis of contemporary clinical studies.
METHODS: To identify all contemporary case-control and population-based AAA screening studies evaluating the association of COPD with AAA presence, databases including MEDLINE and EMBASE were searched from January 2000 to May 2015 using Web-based search engines (PubMed and OVID). An adjusted odds ratio (OR) and 95% confidence intervals (CI) for COPD or AAA presence (using multivariable logistic regression) were abstracted from each individual study. We took an OR for AAA presence to be representative of an OR for COPD presence.
RESULTS: Of 159 potentially relevant articles screened initially, there were 7 case-control and 4 population-based AAA screening studies that met eligibility requirements and were included. Pooled analysis of all the 11 studies (14 estimates, 155,731 participants), 7 case-control studies (4171 participants), and 4 population-based AAA screening studies (7 estimates, 151,560 participants) respectively demonstrated a statistically significant 1.78-fold (OR 1.78, 95% CI 1.38-2.30, P < 0.00001), 3.05-fold (OR 3.05, 95% CI 1.44-6.49, P = 0.004), and 1.24-fold (OR 1.24, 95% CI 1.04-1.48, P = 0.02) increased prevalence/incidence of COPD in patients with AAA relative to subjects without AAA (i.e., a statistically significant 1.78-, 3.05-, and 1.24-fold increased prevalence/incidence of AAA in patients with COPD relative to subjects without COPD) (P for subgroup differences = 0.02).
CONCLUSION: The present meta-analysis demonstrated 1.8-fold increased prevalence/incidence of COPD in patients with AAA relative to subjects without AAA (i.e., 1.8-fold increased prevalence/incidence of AAA in patients with COPD relative to subjects without COPD), which suggests that COPD is associated with AAA presence.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27189132     DOI: 10.1016/j.avsg.2015.12.023

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  5 in total

1.  Lung-derived HMGB1 is detrimental for vascular remodeling of metabolically imbalanced arterial macrophages.

Authors:  Ludovic Boytard; Tarik Hadi; Michele Silvestro; Hengdong Qu; Andrew Kumpfbeck; Rayan Sleiman; Kissinger Hyppolite Fils; Dornazsadat Alebrahim; Francesco Boccalatte; Matthias Kugler; Annanina Corsica; Bruce E Gelb; Glenn Jacobowitz; George Miller; Chiara Bellini; Jessica Oakes; Jean-Sébastien Silvestre; Lior Zangi; Bhama Ramkhelawon
Journal:  Nat Commun       Date:  2020-08-27       Impact factor: 14.919

2.  The TAGA Study: A Study of Factors Determining Aortic Diameter in Families at High Risk of Abdominal Aortic Aneurysm Reveal Two New Candidate Genes.

Authors:  Olga Peypoch; Ferran Paüls-Vergés; Miquel Vázquez-Santiago; Jaime Dilme; Jose Romero; Jordi Giner; Vicente Plaza; Jose Roman Escudero; Jose Manuel Soria; Mercedes Camacho; Maria Sabater-Lleal
Journal:  J Clin Med       Date:  2020-04-24       Impact factor: 4.241

3.  Plasma Metabolomics Analysis Identifies Abnormal Energy, Lipid, and Amino Acid Metabolism in Abdominal Aortic Aneurysms.

Authors:  Yaming Guo; Shuwei Wan; Mingli Han; Yubo Zhao; Chuang Li; Gaopo Cai; Shuai Zhang; Zhi Sun; Xinhua Hu; Hui Cao; Zhen Li
Journal:  Med Sci Monit       Date:  2020-12-01

Review 4.  Angiotensin-converting enzyme 2, coronavirus disease 2019, and abdominal aortic aneurysms.

Authors:  Baohui Xu; Gang Li; Jia Guo; Toru Ikezoe; Karthikeshwar Kasirajan; Sihai Zhao; Ronald L Dalman
Journal:  J Vasc Surg       Date:  2021-02-15       Impact factor: 4.268

Review 5.  AAA Revisited: A Comprehensive Review of Risk Factors, Management, and Hallmarks of Pathogenesis.

Authors:  Veronika Kessler; Johannes Klopf; Wolf Eilenberg; Christoph Neumayer; Christine Brostjan
Journal:  Biomedicines       Date:  2022-01-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.